ArticleNaunyn-Schmiedeberg's archives of pharmacology2024
Metadata analysis of retracted fake papers in Naunyn-Schmiedeberg's Archives of Pharmacology.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- AI hallucinations in academic writing: implications for research integrity.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Scientific retractions: causes, processes, and implications for research integrity.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- The Erosion of Healthcare and Scientific Integrity: A Growing Concern.Journal of healthcare leadership · 2025Review
- How to fight fake papers: a review on important information sources and steps towards solution of the problem.Naunyn-Schmiedeberg's archives of pharmacology · 2024Review
- The undeclared use of third-party service providers in academic publishing is unethical: an epistemic reflection and scoping review.Naunyn-Schmiedeberg's archives of pharmacology · 2024Article
- Clarifying middle authorship contributions to reduce abuses in science publishing and assessment of top-ranked SJR biochemistry and pharmacology journals' authorship criteria.Naunyn-Schmiedeberg's archives of pharmacology · 2024Article
- Combating Fake Science in the Age of Generative Artificial Intelligence: A Biomedical Perspective.Missouri medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An increasing fake paper problem is a cause for concern in the scientific community. These papers look scientific but contain manipulated data or are completely fictitious. So-called paper mills produce fake papers on a large scale and publish them in the name of people who buy authorship. The aim of this study was to learn more about the characteristics of fake papers at the metadata level. We also investigated whether some of these characteristics could be used to detect fake papers. For that purpose, we examined metadata of 12 fake papers that were retracted by Naunyn-Schmiedeberg's Archives of Pharmacology (NSAP) in recent years. We also compared many of these metadata with those of a reference group of 733 articles published by NSAP. It turned out that in many characteristics the fake papers we examined did not differ substantially from the other articles. It was only noticeable that the fake papers came almost exclusively from a certain country, used non-institutional email addresses more often than average, and referenced dubious literature significantly more often. However, these three features are only of limited use in identifying fake papers. We were also able to show that fake papers not only contaminate the scientific record while they are unidentified but also continue to do so even after retraction. Our results indicate that fake papers are well made and resemble honest papers even at the metadata level. Because they contaminate the scientific record in the long term and this cannot be fully contained even by their retraction, it is particularly important to identify them before publication. Further research on the topic of fake papers is therefore urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.